2026 NPPES data Neuro-ophthalmology Physician NPI 1023036340 M.D.
Verify on CMS →

DEBORAH FRIEDMAN, M.D.

Neuro-ophthalmology Physician in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
128
Medicare Part D claims · 45 beneficiaries · Neuro-ophthalmology Physician avg: 419
Generic prescribing
57%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$66.9K
49 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DEBORAH FRIEDMAN, M.D. filed 128 Medicare Part D claims in 2023 as a Neuro-ophthalmology Physician in DALLAS, Texas, prescribing 57% generic.

128
Part D claims, 2023
57%
generic prescribing
$66.9K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DEBORAH FRIEDMAN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

128 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

DEBORAH FRIEDMAN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DEBORAH FRIEDMAN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 07/17/2006

NPI 1023036340

Primary specialty

Neuro-ophthalmology Physician

Rare

128 US NPIs in this specialty

Medicare Part D claims

128 69% vs specialty avg

2023 prescription claims

Specialty avg: 419

Specialty distribution in Texas

How Neuro-ophthalmology Physician compares to other specialties among Texas providers

Texas providers

Neuro-ophthalmology Physician share within Texas

1. Neuro-ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuro-ophthalmology Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Neuro-ophthalmology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Neuro-ophthalmology Physician ABMS/AOA estimate

Est. board-certified rate (Neuro-ophthalmology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Neuro-ophthalmology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEBORAH FRIEDMAN, M.D. appears in the CMS NPPES registry as a Neuro-ophthalmology Physician provider holding M.D. credentials at 12740 HILLCREST RD STE 269, DALLAS, TX, 75230, with a listed phone of (972) 773-9003. NPI 1023036340 was issued on 07/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FRIEDMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 128 prescription claims written by this provider, covering 45 Medicare beneficiaries and totaling roughly $83K in drug spend, split 43% brand-name and 57% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Neuro-ophthalmology Physician is a narrow specialty nationwide, with 128 enrolled providers across 34 states and an average of 419 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12740 HILLCREST RD STE 269
DALLAS, TX 75230

Provider Details

NPI 1023036340
Specialty Neuro-ophthalmology Physician
Credentials M.D.
Gender Female
NPI Issued 07/17/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEBORAH FRIEDMAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$66.9K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to DEBORAH FRIEDMAN, M.D.. To verify DEBORAH FRIEDMAN, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

DEBORAH FRIEDMAN, M.D. — brand share 43.0%
Specialty average (est.)

43% brand-name claims vs 57% generic, on 128 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

128
Total Claims
$83K
Total Drug Cost
45
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
185
Total Day Supply
5,028
Brand vs Generic
43% brand / 57% generic
Brand Drug Cost
$66K
Generic Drug Cost
$17K

Patient Demographics

Average Patient Age
59.7 years
Avg HCC Risk Score
1.38
Age Distribution
<65: 27, 65-74: 11, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Aimovig Autoinjector
Erenumab-Aooe
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuro-ophthalmology Physician Overview

How DEBORAH FRIEDMAN, M.D. fits within the Neuro-ophthalmology Physician landscape nationally.

128
Neuro-ophthalmology Physician Providers in US
34
States with Neuro-ophthalmology Physician
419
Avg Claims per Provider

DEBORAH FRIEDMAN, M.D.'s 128 claims are below the specialty average of 419.

Nearby Neuro-ophthalmology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as FRIEDMAN.

Compare Neuro-ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEBORAH FRIEDMAN, M.D.'s specialty?
DEBORAH FRIEDMAN, M.D. specializes in Neuro-ophthalmology Physician and practices in DALLAS, Texas. Credentials: M.D..
How much does DEBORAH FRIEDMAN, M.D. prescribe under Medicare Part D?
In 2023, DEBORAH FRIEDMAN, M.D. wrote 128 Medicare Part D claims totaling $83K in drug costs for 45 beneficiaries.
Where is DEBORAH FRIEDMAN, M.D. located?
DEBORAH FRIEDMAN, M.D. is located at 12740 HILLCREST RD STE 269, DALLAS, TX, 75230. Phone: (972) 773-9003.
What is DEBORAH FRIEDMAN, M.D.'s NPI number?
DEBORAH FRIEDMAN, M.D.'s National Provider Identifier (NPI) is 1023036340, issued on 07/17/2006.
Does DEBORAH FRIEDMAN, M.D. prescribe more brand-name or generic drugs?
DEBORAH FRIEDMAN, M.D.'s prescribing is 43% brand-name and 57% generic drugs by claim count, with $66K in brand drug costs.
How many Neuro-ophthalmology Physician providers are there in the US?
There are 128 Neuro-ophthalmology Physician providers across 34 states in the US. The average Neuro-ophthalmology Physician provider writes 419 Medicare Part D claims per year.
What drugs does DEBORAH FRIEDMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DEBORAH FRIEDMAN, M.D.'s most frequently prescribed drugs include Aimovig Autoinjector. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEBORAH FRIEDMAN, M.D. accept Medicare?
DEBORAH FRIEDMAN, M.D. appears in CMS Medicare data with 128 Part D claims and 45 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEBORAH FRIEDMAN, M.D.'s credentials?
DEBORAH FRIEDMAN, M.D.'s NPI is 1023036340 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology